Limiting-dilution cell transplantation revealed that Notch signaling does not increase the overall frequency of leukemia-propagating cells (LPCs), either alone or in collaboration with Myc.

PMB212 blocks most of the signaling pathways related to cancer stemness in cells, including those mediated by Wnt, Notch, Hedgehog, Hippo, and STAT3. Moreover, PMB212 prevents epithelial to ...

Notch Therapeutics is making “significant ... including Allogene-partnered induced-pluripotent-stem-cell-derived T cells. It’s also working on a CD19- and CD20-focused CAR therapy, among ...

R3 Stem Cell is offering highest grade immunotherapy with Natural Killer Cells in Tijuana Mexico. The immunotherapy works well for several cancer treatments. The goal with NK Cell immunotherapy ...

Vancouver, BC, February 10, 2025-- (T-Net)-- Notch Therapeutics issued a statement recently indicating that the company is taking steps to preserve cash and explore alternative paths forward after ...

Dr. Weickert will present Pacylex at the OBIO® Investment Summit and Early Technology Showcase February 5-7, 2025, at the Arcadian Court & Loft, Toronto Mr. Kamdar will present Pacylex at the PWMC ...